New additions to our portfolio – Stage I March 2024
Just two days before the 8th AMR Conference opened its [...]
The busy and insightful AMR week in Basel
The AMR conference has established itself as the premier European [...]
Highlights of the workshop “Phages: what’s new and what’s next?”
Basel was definitely the place to be in the week [...]
Kick-off the busy week: Selection Committee Meeting
Basel is the place to be this week, and believe [...]
Xiretsa wins Stage II Funding: boosting a new class of Antibiotics
February 2024 – Xiretsa, Inc is the second selected venture [...]
SPRIND calls for unconventional innovations to fight AMR
Do you have an outstanding antimicrobial resistance (AMR) innovation that [...]
The finalists for the Start-up Pitch Event have been chosen!
After receiving over 40 applications and going through a rigorous [...]
Look back on 2023
As December arrives and 2023 draws to a close, it's [...]
INCATE and Kineticos join forces in supporting AMR innovators
December 6th 2023 – INCATE (the INCubator for Antibacterial Therapies [...]
STAGE I October 2023 selection
The INCATE Selection Committee selected the last 4 new ventures [...]
